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Abstract:  
Stroke remains one of the most devastating of all neurological diseases, often causing death or gross physical 
impairment or disability. Homocysteine is one of the modifiable risk factor regarding this.  
Objectives: To determine the frequency of raised homocysteine level in patients of ischemic stroke.  
Material and methods. This was a cross sectional study that was conducted at Kishwar Fazal teaching hospital 
Sheikhupura during January to July 2017, in which 146 cases with age range of 40 to 70 years of both gender 
suffering from ischemic stroke were included and were assessed for their homocysteine level. 
Results; In this study there were 146 cases out of which 76 (52.05%) were males and 70 (47.95%) females. The 
mean age was 56.25± 7.67 years and mean BMI was 29.52± 3.42. There were 40 (27.40%) cases with DM, 48 
(32.88%) hypertensive, 46 (31.51%) had history of smoking while 18 (12.33%) had family history of ischemic 
stroke. Raised homocysteine level was seen in 58 (33.70%) cases.  Raised homocysteine level was more seen in 
females where it was seen in 32 (45.71%) out of 70 females as compared to 26 (34.21%) out of 76 males with p 
values of 0.32. This raised level was also seen maximum in age groups of 60 to 70 years affecting 28 (45.14%) out 
of 62 cases (p=0.43). There was no significant association with any of the risk factors with raised homocysteine 
level.  
Conclusion: Ischemic stroke is a fatal condition. Raised homocysteine level is seen in every 3rd cases of ischemic 
stroke. Hypertension and family history of ischemic stroke has almost significant association with it. 
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Stroke remains one of the most devastating of all 
neurological diseases, often causing death or gross 
physical impairment or disability. Worldwide, Asia, 
Russia and Eastern Europe experience the highest 
rates of mortality and disability and loss of quality of 
life because of stroke.[1-2]. 
Atherosclerosis, diabetes mellitus (DM), 
hypertension (HTN), ischemic heart disease (IHD), 
peripheral arterial diseases are the known risk factors 
for ischemic stroke. But they are unavoidable and 
non-modifiable risk factors. It is seen that a good 
number of cases, these well studied risk factors are 
even absent too. [3] This opens the horizon to look 
for new or undiscovered and if possible, the 
modifiable risk factors associated with stroke. 
Homocysteine (Hcy) excess is one of those risk 
factors ,which are modifiable and recently work is 
going on globally to look for its importance and their 
role in ischemic stroke.  
The raised level of homocysteine occurs due to 
deviation in the metabolism of Methionine, which is 
an essential amino acid; leading to hyper coagulable 
state which cause clotting in blood vessels and lead to 
ischemic infarcts in brain. It is affected by many 
factors like age, vitamin B6, B12, Folic acid and 
intake of certain drugs like steroids and cyclosporine. 
Han L et al revealed that the raised levels of 
homocysteine were not only directly associated with 
increased risk of stroke but also with the severity of 
the ischemic stroke and folic acid was found useful 
for its prevention.4 According to a study by 
Ashjazeda N et al carried on 171 cases of ischemic 
stroke as compared to 82 matched controls, the 
homocysteine level was found significantly raised in 
cases with ischemic stroke as compared to controls. 
The mean fasting Hcy levels was significantly higher 
in the cases (16.2 μmol/L, 95% CI: 14.8 to 17.5) than 
in the controls (13.5 μmol/L, 95% CI: 12.4 to 14.6) 
(P=0.013) [5] 
According to a study by Sadiq M et al it was seen 
that raised levels of homocysteine was seen in 58.3% 
of cases in their study at Karachi. [6] Another study 
from Bangladesh, done by Rehman et al on 36 
patients showed that raised homocysteine levels were 
seen in 75% of the cases. [7] 
Objective: 
The objective of this study was to determine the 
frequency of raised homocysteine level in patients of 
ischemic stroke in people of Rahim Yar Khan.  
 
MATERIALS AND METHODS: 
This was a cross sectional study that was conducted 
at Kishwar Fazal teaching hospital Sheikhupura 
during January to July 2017, in which 146 cases of 
ischemic stroke were included with following 
inclusion and exclusion criteria. 
 
Inclusion criteria. Gender: both male and female 
 Age: 40 – 70 years 
 All the patient with ischemic stroke (as per 
operational definition) presenting within 1 week 
of the symptoms. 
 
Exclusion criteria 
 Patients with hemorrhagic stroke (hyperdense 
area on CT brain plain in at least 3 slices) 
 Patients with any history of prior stroke in life 
time. 
 Patients taking drugs like 




The patients were labeled as having hemorrhagic 
stroke, when he or she had a history of severe 
headache and sudden loss of movement in one or 
more than one parts of the body. The diagnosis was 
confirmed on CT scan brain (hyper dense area in the 
brain in at least 3 slices).  
Hyperlipidemia:  
Hyperlipidemia was labeled ‘yes’ when there was 
any of the following lipid values observed: 
1. High serum LDL-C levels: >100mg/dl  
2. Hypertriglyceridemia =  serum triglycerides 
level: >150mg/dl 
3. Hypercholestrolemia= Cholesterol level >200 
mg/dL 
4. Low HDL: <40 mg/dL 
 
Statistical Analysis: 
In this cross sectional study, all the collected data 
were entered into SPSS version 21 and analyzed. The 
qualitative data like sex, DM, HTN, Smoking, family 
history of ischemic stroke, raised level of 
homocysteine (yes/no) were assessed as frequency 
and percentages. Quantitative data like age, weight, 
height, BMI, homocysteine level (µmol/L) and 
duration of symptoms (days) were assessed as means 
and standard deviations. Post stratification chi square 




In this study there were 146 cases out of which 76 
(52.05%) were males and 70 (47.95%) females. The 
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mean age was 56.25± 7.67 years and mean BMI was 
29.52± 3.42. There were 40 (27.40%) cases with DM, 
48 (32.88%) hypertensive, 46 (31.51%) had history 
of smoking while 18 (12.33%) had family history of 
ischemic stroke. Raised homocysteine level was seen 
in 58 (33.70%) cases.  Raised homocysteine level 
was more seen in females where it was seen in 32 
(45.71%) out of 70 females as compared to 26 
(34.21%) out of 76 males with p values of 0.32 as 
shown in table 1. This raised level was also seen 
maximum in age groups of 60 to 70 years affecting 
28 (45.14%) out of 62 cases followed by 40 to 49 
year in 16 (44.44%) out of 36 cases with p values of 
0.43 as in table 2. There was no significant 
association with any of the risk factors with raised 
homocysteine level as in table 3.  
 
TABLE 01: RAISED HOMOCYSTEINE LEVEL WITH RESPECT TO GENDER n= 146 
Chi square= 1.007, p= 0.32 
TABLE 02: RAISED HOMOCYSTEINE LEVEL WITH RESPECT TO AGE GROUPS  n= 146 
 
Chi square= 1.667, p= 0.43 
 
GENDER 
RAISED HOMOCYSTEINE LEVEL 
Total 
Yes No 
MALE  26 (34.21%) 50 (65.79%) 76 (100%) 
FEMALE  32 (45.71%)  38 (54.29%) 70 (100%) 
Total 58 (69.8%) 88 (30.2%) 146 (100%) 
Age Group 
RAISED HOMOCYSTEINE LEVEL 
Total 
Yes No 
40 to 49  16 (44.44%) 20 (55.56%) 36 (100%) 
50 to 59  14 (29.17%)  34 (70.83%) 48 (100%) 
60 to 70 28 (45.16%)  34 (54.84%) 62 (100%) 
Total 58 (69.8%) 88 (30.2%) 146 (100%) 
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TABLE 03: RAISED HOMOCYSTEINE LEVEL WITH RESPECT TO STUDY VARIABLES n= 146 




  Yes No  
 
 Yes 12 28 Chi sq.=1.08 
DM 
 












Chi sq. = 0.07 
 












































Chi sq.= 0.11 
 
P=0.73 
 More than 30 30 42  
 
DISCUSSION: 
Stroke remains one of the most devastating of all 
neurological diseases, often causing death or gross 
physical impairment or disability. Worldwide, Asia, 
Russia and Eastern Europe experience the highest 
rates of mortality and disability and loss of quality of 
life because of stroke. 
 
Raised homocysteine level was seen in 58 (33.70%) 
cases.  Similar was seen by other studies as well. [8-
10] The mechanism behind this ischemic stroke is 
that it increases the tendency of the blood to clot. The 
above mentioned studies have also build up the 
association that raised homocysteine level increases 
the likelihood of developing stroke not only in the 
smaller vessels but also with the larger ones.[8-10] 
Even the studies have shown this raised level in as 
high as 75% of the cases. The reason of such higher 
number in contrast to our study is unknown. The 
mortality was not assessed in this study but a study 
from China has seen for this association. They have 
noted that elevated tHcy levels during the acute phase 
of an ischemic stroke significantly increased the 
mortality chances. In this study majority of the cases 
were in 2nd quartiles of the Hcy level and that study 
has revealed that the cases with 3rd and the 4th 
quartiles had a 1.83-fold or higher increased risk of 
death after the 48 months of stroke compared with 
patients in the first quartile. After multivariate 
analysis, this association remained statistically 
significant. [12] 
Raised homocysteine level was seen in females 
where it was seen in 32 (45.71%) out of 70 females 
as compared to 26 (34.21%) out of 76 males; though 
this difference was not statistically significant with p 
values of 0.32. A study by Hung et al showed that 
resistant hypertension was associated with a higher 
risk of IS, especially in women and elderly patients. 
[13] The Framingham Heart Study also suggested 
overall higher lifetime stroke susceptibility in 
women. Estrogen and estrogen–progestogen therapy 
can reduce homocysteine levels in menopausal 
women. Another study suggested that higher levels of 
estrogen–homocysteine conjugates could lead to a 
lowering of homocysteine-induced cardiovascular 
disease (CVD) risk. Here we observed that elderly 
women tended to have higher tHcy levels, perhaps 
because of the lower estrogen levels in older women. 








This raised level was also seen maximum in age 
groups of 60 to 70 years affecting 28 (45.14%) out of 
62 cases followed by 40 to 49 year in 16 (44.44%) 
out of 36 cases. This difference was also not found 
significant with p values of 0.43. This was also 
observed by many studies. [17] It can be explained 
by many ways. The higher age was with this 
increased tendency was explained in females due to 
hormonal changes. The other factors can be multiple 
nutritional factor deficiencies like vitamin and 
antioxidant which is decreased in older age groups to 
either poor intake or development o co morbidities 
like GI problems, malignancies etc. that can also 
either enhance their consumption or decrease their 
absorption. Contrary to all this, on the other hand the 
other group which was found higher in this study was 
relatively young group with age 40 to 49 years. The 
reason for higher age groups in relatively young age 
group can be due to genetic factors that were also 
observed by other studies. However they also did not 
found significant association. [18-19]. 
In this study the ischemic stroke was seen in 18 out 
of 30 cases with a near significant p value of 0.07. 
This was also seen by other studies that found in 
higher number. [13-14] Moreover, Yan et al reported 
that women with mild hypertension had a higher risk 
of stroke than men and showed that a 10 mm Hg 
increase in SBP was associated with a 38% increased 
risk of stroke in women. The other mechanisms 
involved include the history of pre-existing 
atherosclerosis, which is also an out come of DM and 
HTN. Conflicting results have been found regarding 
association between homocysteine levels and 
diabetes mellitus.  [20] 
The cases with family history of ischemic stroke 
were found in 8 out of 18 cases with p value of 0.09. 
This higher number can be explained by the present 
of genetic factors. Multiple genetic mutations have 
been proposed to support this theory with higher Hcy 
levels than those without pre-existing atherosclerosis. 
It seems that there is an association between 
economic prosperity and the risk of stroke. Higher 
prevalence of Hcy in many developing countries 
could indicate the role of inadequate intake of 
vitamins and antioxidants in the multi-factorial 
causes of stroke. The effect of genetic factors on 
hyperhomocysteinemia is also important. In fact, 
these factors may confound the results of 
epidemiological studies and may render the results 
statistically unstable. [21-23]. 
There were few limitations to this study. As this 
study did not check for the type of vessel involved to 
development of stroke and it also did not check for 
the association of raised level with the severity of the 
stroke. 
CONCLUSION: 
Ischemic stroke is a fatal condition. Raised 
homocysteine level is seen in every 3rd cases of 
ischemic stroke. Hypertension and family history of 
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